Groowe Groowe / Newsroom / SKYE
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SKYE News

Skye Bioscience, Inc. Common Stock

Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm

globenewswire.com
SKYE

Lifshitz Law PLLC Announces Investigations of StubHub Holdings, Inc. (NYSE:STUB), Skye Bioscience, Inc. (NASDAQ:SKYE), Primo Brands Corporation (NYSE:PRMB), and Freeport-McMoRan Inc. (NYSE:FCX)

accessnewswire.com
STUB SKYE PRMB FCX

Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit

globenewswire.com
SKYE

Form 8-K/A

sec.gov
SKYE

Form 8-K

sec.gov
SKYE LGND

Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development

globenewswire.com
SKYE

Skeyeon Secures Key Patent for Very-Low Earth Orbit Satellite Constellations with Onboard Imaging and Direct-to-Ground Data Delivery Enabling Near-Real-Time Earth Observation

businesswire.com
SKYE

Form 8-K

sec.gov
SKYE

Form 8-K

sec.gov
SKYE

Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

globenewswire.com
SKYE